FDA Inspection 1310324 — Lawrence Berkeley National Laboratory IRB

Lawrence Berkeley National Laboratory IRB — FEI 3004968566

The FDA completed an inspection of Lawrence Berkeley National Laboratory IRB on February 13, 2026 in Berkeley, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.